Lataa...
Back from the brink: EGFR inhibition in gastroesophageal cancer
Gastroesophageal adenocarcinomas (GEA) remain difficult to treat with limited targeted therapeutics. Negative results from randomized trials of Epidermal Growth Factor Receptor inhibitors (EGFRi) in molecularly unselected GEA patients have hampered the development of EGFRi in the gastroesophageal ca...
Tallennettuna:
| Julkaisussa: | Clin Cancer Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7617050/ https://ncbi.nlm.nih.gov/pubmed/33771852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-21-0533 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|